CinCor Pharma, Inc.
CIK 0001868734
Revenue (TTM)
—
Q3 Nov 2022
Net Income (TTM)
−$67.77M
−125.9% YoY
Q3 Nov 2022
EPS Diluted (TTM)
—
Q3 Nov 2022
Gross Margin
—
Q3 Nov 2022
Operating Margin
—
Q3 Nov 2022
Net Margin
—
Q3 Nov 2022
Free Cash Flow (TTM)
—
Q3 Nov 2022
Cash
$292.56M
Q3 Nov 2022
Total Debt
—
Q3 Nov 2022
Shares Outstanding
43.76M sh
Q3 Nov 2022
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.